Drug Profile
Phosphinic cyclocreatine
Alternative Names: Ph CCrLatest Information Update: 20 Sep 2006
Price :
$50
*
At a glance
- Originator Amira
- Class Antivirals; Small molecules
- Mechanism of Action Creatine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cytomegalovirus infections; Herpes simplex virus infections
Most Recent Events
- 21 Jul 1998 No-Development-Reported for Cytomegalovirus infections in USA (Unknown route)
- 21 Jul 1998 No-Development-Reported for Herpes simplex virus infections in USA (Unknown route)
- 28 Sep 1995 New profile